Objective:
To describe outcomes after elective and non-elective fenestrated-branched endovascular aortic repair (FB-EVAR) for thoracoabdominal aortic aneurysms (TAAAs).
Summary of Background Data:
FB-EVAR has been increasingly utilized to treat TAAAs; however, outcomes after non-elective versus elective repair are not well described.
Methods:
Clinical data of consecutive patients undergoing FB-EVAR for TAAAs at 24 centers (2006-2021) were reviewed. Endpoints including early mortality and major adverse events (MAEs), all-cause mortality, and aortic-related mortality (ARM), were analyzed and compared in patients who had non-elective versus elective repair.
Results:
A total of 2,603 patients (69% males; mean age 72±10 y-old) underwent FB-EVAR for TAAAs. Elective repair was performed in 2,187 patients (84%) and non-elective repair in 416 patients (16%; 268 [64%] symptomatic, 148 [36%] ruptured). Non-elective FB-EVAR was associated with higher early mortality (17% vs. 5%, P<0.001) and rates of MAEs (34% vs. 20%, P<0.001). Median follow-up was 15 months (interquartile range, 7-37 mo). Survival and cumulative incidence of ARM at 3-years were both lower for non-elective versus elective patients (50±4% vs. 70±1% and 21±3% vs. 7±1%, P<0.001). On multivariable analysis, non-elective repair was associated with increased risk of all-cause mortality (hazard ratio [HR], 1.92; 95% confidence interval [CI], 1.50-2.44; P<0.001) and ARM (HR, 2.43; 95% CI, 1.63-3.62; P<0.001).
Conclusions:
Non-elective FB-EVAR of symptomatic or ruptured TAAAs is feasible, but carries higher incidence of early MAEs and increased all-cause mortality and ARM than elective repair. Long-term follow-up is warranted to justify the treatment.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.